Skip to main content
MyCapitol LogoMyCapitol

S 483 · 119th Congress

Responsibility in Drug Advertising Act of 2025

This bill puts a three-year pause on drug companies advertising new medications directly to consumers. That means you won't see ads on social media, TV, or other platforms promoting a brand-new drug during its first three years on the market. The idea is to give the FDA time to monitor how the drug actually performs…

Sponsor
King, Angus S., Jr. (I-Maine)
Introduced
2025-02-06
Policy area
Health
Latest action
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Digging through Congress... 🔍